Activist Shah Capital Exits 13D Status, Sells 2.87M Novavax Shares in Family-Office Restructuring

summarizeSummary

Shah Capital converted from an activist 13D filer to a passive 13G filer, sold 2.87M Novavax shares at ~$11.35, and moved its holdings into a family office. It still owns 6.39% of the company.

check_boxKey Events · Ownership and Investor Activity · NVAX

• Shah Capital Drops Activist 13D Status

  Effective October 16, 2026, Shah Capital withdrew its SEC investment adviser registration and said it no longer holds shares with a purpose of influencing control, moving to Schedule 13G reporting.

• 2.87M Shares Sold at ~$11.35

  Shah Capital Fund LLC sold 2,870,000 shares at an average price of $11.3486 as of October 5, 2026, roughly $32.6M in proceeds (2,870,000 x $11.3486).

• Family-Office Restructuring

  Himanshu Shah formed Himanshu Shah Family Office LLC and Shah Capital Fund LLC to manage family investments, replacing Shah Capital Management as the management vehicle.

• Remaining Stake 6.39%

  Shah Capital Management still beneficially owns 10,543,476 shares (6.39%) and Himanshu H. Shah 10,656,964 shares (6.46%), based on 165M shares outstanding as of July 31, 2026.

auto_awesomeAnalysis · NVAX · Life Sciences

Shah Capital, a long-time 13D filer, is stepping back from its activist posture: it withdrew its SEC investment adviser registration, folded its holdings into a family office, and told the market it will report on passive Schedule 13G going forward. The same filing discloses it sold 2,870,000 shares at an average of $11.3486 (~$32.6M) as of October 5, 2026. Losing an engaged holder removes a potential source of pressure on management, and the sale adds supply to a stock that already trades thinly relative to its float. The remaining stake is still meaningful — 10,543,476 shares, or 6.39% of the 165M shares outstanding as of July 31, 2026 — so this is a reduction in engagement, not a full exit.